Targeted News Service

GeneOne and Wistar Institute Collaborate to Develop Small Molecule Therapeutics to Protect Humans From Nipah Virus
May 11, 2023

PHILADELPHIA, Pennsylvania, May 11 (TNSres) -- The Wistar Institute issued the following news release:

GeneOne Life Science, Inc.("GeneOne" KOSPI: 011000), a leading biopharmaceutical company specializing in developing nucleic-acid based treatments and novel small-molecule therapeutics, and The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, headquartered in Philadelphia, Pennsylvania, announ . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form